babycakes,
I'm not sure what maine's argument was. That we're too optimistic about CYGX's future?
CYGX's future prospects haven't changed. Some people were here just for the stock ride. Fine. Some people are here because they think the company has the technology to make it big in the DNR/RNA medicine explosion that's going on right now.
Were we too optimistic about the where the stock price might go? I had no certainty about where it would go in the short term. I'd hoped for better than what we have at the moment, of course, but I also knew that a firm gain would come only with contracts, licensing, and the moving of our own stuff into trials.
That's all still ahead.
Nothing's changed except the traders have momentarily gone, and the stock price is only nine times what it was when I started looking at this company. That's not a terrible retracing as stocks go, really.
All maine ever expressed other than a disdain at any optimism toward the company's prospects was that it was somehow worthless. He was wrong then and he still is.
I watched Peregrine Pharmaceuticals stock price fall from two dollars down to thirty cents. Now it's bouncing around back in the mid two's again, and the company's future looks brighter than ever.
Peregrine wasn't worthless when its stock dipped and neither is CYGX.
Th